[Methotrexate].
Suzuki
Yasuo
Y
Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine.
D000203:Activities of Daily Living; D018501:Antirheumatic Agents; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000503:physiopathology; D016903:Drug Monitoring; D005492:Folic Acid / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D011379:Prognosis
D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D005492:Folic Acid; D008727:Methotrexate